Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults

Posaconazole is a potent broad-spectrum triazole antifungal. Little is known about the prevalence and risk factors for low plasma posaconazole concentrations (PPCs). We retrospectively reviewed all adult patients whose PPCs were measured after at least 5 days of treatment between April 2006 and July...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Lebeaux, David, Lanternier, Fanny, Elie, Caroline, Suarez, Felipe, Buzyn, Agnès, Viard, Jean-Paul, Bougnoux, Marie-Elisabeth, Lecuit, Marc, Jullien, Vincent, Lortholary, Olivier
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology (ASM) 2009
Konular:
Clinical Therapeutics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2786318/
https://ncbi.nlm.nih.gov/pubmed/19752284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00939-09
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller